What's new

Human medicines European public assessment report (EPAR): Skilarence, dimethyl fumarate, Date of authorisation: 23/06/2017, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Skilarence, dimethyl fumarate, Date of authorisation: 23/06/2017, Revision: 13, Status: Authorised

Mar 17, 2025 - 17:11
 0
Human medicines European public assessment report (EPAR): Skilarence, dimethyl fumarate, Date of authorisation: 23/06/2017, Revision: 13, Status: Authorised
Human medicines European public assessment report (EPAR): Skilarence, dimethyl fumarate, Date of authorisation: 23/06/2017, Revision: 13, Status: Authorised
Read More

Tags:

Previous Article

Merck plots 163 layoffs as it prepares to shutter Pennsylvania manufacturing site

Next Article

Human medicines European public assessment report (EPAR): Cejemly, sugemalimab, ...

Related Posts

Type-IB variations: questions and answers

Type-IB variations: questions and answers

Feb 18, 2025  0

Conversations on cancer - cervical cancer treatment innovation: a collaborative discussion , European Medicines Agency, Amsterdam, the Netherlands, from 14 January 2025, 16:00 (CET) to 14 January 2025, 17:00 (CET)

Conversations on cancer - cervical cancer treatment inn...

Feb 14, 2025  0

Veterinary medicines European public assessment report (EPAR): Nobilis Multriva REOm, avian reovirus vaccine (inactivated), Status: Authorised

Veterinary medicines European public assessment report ...

Mar 7, 2025  0